Publication:
Administration of meloxicam to cows experiencing dystocia does not increase the incidence of retained placenta

dc.contributor.authorKunz, Fabian
dc.contributor.authorFailing, Klaus
dc.contributor.authorWehrend, Axel
dc.contributor.authorSendag, Sait
dc.contributor.buuauthorKOCA, DAVUT
dc.contributor.departmentBursa Uludağ Üniversitesi/Veteriner Fakültesi/Jinekoloji ve Doğum Anabilim Dalı.
dc.contributor.orcid0000-0002-7962-6959
dc.contributor.researcheridAAI-6709-2021
dc.date.accessioned2024-10-25T11:22:57Z
dc.date.available2024-10-25T11:22:57Z
dc.date.issued2019-10-01
dc.description.abstractObjective The post partum use of analgesics in cows has increased in consequence to society's increased awareness of animal welfare. However, it is known that the post partum administration of a subset of nonsteroidal anti-inflammatory drugs to cows may lead to an increased rate of retained placenta. Therefore, the aim of this study was clarify, whether a single administration of meloxicam to cows that experienced dystocia results in an increased rate of this disease.Material and methods The study was conducted in 63 Holstein-Friesian cows in 4 farms with random allocation into 2 groups: In animals of the treatment group (n = 27) a single subcutaneous injection of meloxicam (0.5 mg/kg) was administered within 2-8 hours after calving. The animals of the control group (n = 36) received the same volume of a bovine infusion solution (Amynin (R), bovine infusion solution, Boehringer Ingelheim) subcutaneously. A clinical examination of the cows was performed on the day of parturition and on the 21st day post partum. Findings on the days in between were obtained by questioning of the farmers. The exact Fisher-test was calculated in order to test for statistical differences between the treatment and control groups.Results In cows of the treatment group, retained placenta was not observed more frequently than in cows of the control group.Conclusion and clinical relevance A single administration of meloxicam to cows that experienced dystocia does not increase the incidence of retained placenta.
dc.identifier.doi10.1055/a-0986-3800
dc.identifier.endpage284
dc.identifier.issn1434-1220
dc.identifier.issue5
dc.identifier.startpage281
dc.identifier.urihttps://doi.org/10.1055/a-0986-3800
dc.identifier.urihttps://hdl.handle.net/11452/47108
dc.identifier.volume47
dc.identifier.wos000491346800001
dc.indexed.wosWOS.SCI
dc.language.isoen
dc.publisherGeorg Thieme Verlag Kg
dc.relation.journalTieraerztliche Praxis Ausgabe Grosstiere Nutztiere
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectMilk-production
dc.subjectDairy-cows
dc.subjectCattle
dc.subjectParturition
dc.subjectBehavior
dc.subjectDermatitis
dc.subjectCow
dc.subjectDystocia
dc.subjectNon-steroidal antiphlogistic drugs
dc.subjectRetained placenta
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectVeterinary sciences
dc.titleAdministration of meloxicam to cows experiencing dystocia does not increase the incidence of retained placenta
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublication1ecc600f-e2fa-4fdd-8b8b-c006239e76a8
relation.isAuthorOfPublication.latestForDiscovery1ecc600f-e2fa-4fdd-8b8b-c006239e76a8

Files

Collections